menu

Assessing the Impact of Guiding EBC Treatment Decisions with Prognostic Markers

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Assessing the Impact of Guiding EBC Treatment Decisions with Prognostic Markers

ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Media formats available:
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Comments
  • Sponsored by

  • Overview

    Dr. Pavani Chalasani, Associate Professor of Medicine and Program Director of the Hematology/Oncology Fellowship at the University of Arizona Cancer Center, discusses the utility of prognostic markers to improve outcomes for patients with breast cancer.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Sponsored by

  • Overview

    Dr. Pavani Chalasani, Associate Professor of Medicine and Program Director of the Hematology/Oncology Fellowship at the University of Arizona Cancer Center, discusses the utility of prognostic markers to improve outcomes for patients with breast cancer.

Facebook Comments

Schedule27 Nov 2021
Webpack App